v3.20.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Cash flows from operating activities:    
Net loss $ (2,398) $ (3,786)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 1 2
Stock-based compensation 143 1,446
Noncash interest expense 10
Warrants received as licensing fee (23)
Change in fair value of equity investment (9)
Change in fair value of derivative liabilities (102)
Other expense related to extension of warrants 412
Loss on extinguishment of derivative liability 288
Common stock payable to consultant 844
Changes in operating assets and liabilities:    
Trade receivable (146) (144)
Other accounts receivable and prepaid expenses 110 (38)
Inventory (27) (7)
Trade payables 7 150
Other accounts payable and accrued expenses (91) 75
Deferred revenue 226
Accrued severance pay, net (15) (35)
Net cash used in operating activities (1,378) (1,729)
Cash flows from financing activities:    
Proceeds from issuance of notes payable to a related party 200
Proceeds from issuance of notes payable 42 475
Payments of convertible notes (475)
Proceeds from issuance of Preferred Series E stock 3,200
Proceeds from exercise of options 4
Net cash provided by financing activities 242 3,204
Net increase (decrease) in cash, cash equivalents and restricted cash (1,136) 1,475
Cash, cash equivalents and restricted cash at beginning of period 1,338 896
Cash, cash equivalents and restricted cash at end of period 202 2,371
Supplemental non-cash financing and investing activities:    
Cash paid for interest 5
Cash paid for taxes
Discount on notes payable 123
Discount on convertible notes $ 414

Source